Pharmaceutical compositions containing mesembrine and related compounds
US6288104A · kind A · utility
14Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 1999 |
| Grant date | Sep 11, 2001 |
| Priority date | — |
| Expiry date | Mar 22, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is disclosed the use of mesembrine and related compounds (e.g. mesembranol, mesembranone) as scrotonin-uptake inhibitors, pharmaceutical compositions comprising such compounds or dry material or an extract of plants from the Mesembryanthemaceae family (e.g. Sceletium (Aizoaceae) tortuosum) containing a standardized content of said compounds, for use in the treatment of depressive states, psychological or psychiatric disorders with an anxiety component, alcohol and drug dependence, bulimia nervosa and obsessive-compulsive disorders. Also disclosed are new derivatives of mesembrine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.